title: [Hypopituitarism--substitution therapy].
abstract: Hypopituitarism is a condition linked with insufficient function of the adenohypophyse and occurs in the case of destruction of its greater part. It may take the form of an isolated deficit or a combined disorder--panhypopituitarism. The most common cause is an expansion in the region ofsella turcica, irradiation, traumas, inflammations, bleeding, puerperal ischemic necrosis (Sheehan syndrome) or an affection of the hypothalamus. The cause remains unclear in the case of idiopathic hypopituitarism.
  
  
  METHODS
  The most common case in children is the deficit of the growth hormone, manifested by retarded growth. Sometimes it is combined with the deficit ofgonadotropins which causes pubertas tarda. The clinical picture in adult patients is proportionate to the degree and type of disorder of the different hypophysial functions. Diagnosing of the disease is based on the clinical picture and laboratory examination of hypophysial hormones together with the respective peripheral gland hormones. Dynamic stimulation tests need to be used for more precise diagnosis in the case of threshold results.
  
  
  METHODS
  Expansive processes in the region of the hypophysis are treated by surgery or irradiation, mostly using the gamma knife. Substitution by peripheral gland hormones is used in persistent hormonal deficits. Hypocorticism is treated by hydrocortizone at a dose of 10-30 mg per day administered per os, respecting the diurnal rhythm. The dose should be adjusted in case of strain, and parenterally administered hydrocortizone is necessary in the case of decompensation, pituitary crisis or surgery. Hypothyreosis is treated by thyroxin, the usual substitution dose ranging between 50 and 150 microg per day. The dose is titrated according to the clinical condition and free thyroxin level. Testosterone substitution therapy is used to treat male hypogonadism. In women, a combination of estrogens and gestagens is used on a cyclic or a continuous basis. If fertility is the therapeutic objective, temporary administration of injection gonadotropins or gonadoliberin is necessary in both the sexes. Therapy with growth hormone is indicated in children and in adults with sever, clinically manifested deficit of GH where its administration clearly improves the quality of life, promotes the growth of lean body mass, an increase in bone density and the improvement of metabolic parametres.
authors.affiliation: II. Interní klinika Lékarské fakulty MU a FN u sv. Anny Brno. vera.olsovska@fnusa.cz
authors.forename: V
authors.initials: V
authors.lastname: Olsovská
mesh_terms: D020249:Hormone Replacement Therapy; D006801:Humans; D007018:Hypopituitarism / Q000188:drug therapy* / Q000209:etiology